VMI
VHCP Management II Portfolio holdings
AUM
$379M
This Quarter Return
+24.12%
1 Year Return
+424.39%
3 Year Return
+2,335.22%
5 Year Return
–
10 Year Return
–
AUM
$334M
AUM Growth
+$334M
(-19%)
Cap. Flow
-$134M
Cap. Flow
% of AUM
-40.04%
Top 10 Holdings %
Top 10 Hldgs %
87.99%
Holding
24
New
7
Increased
3
Reduced
2
Closed
6
Top Buys
1 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$28.8M |
2 |
DBVT
DBV Technologies
DBVT
|
$12M |
3 |
Kiniksa Pharmaceuticals
KNSA
|
$11.1M |
4 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
$5.63M |
5 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
$2.44M |
Top Sells
1 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$128M |
2 |
AnaptysBio
ANAB
|
$18.8M |
3 |
Gyre Therapeutics
GYRE
|
$14.3M |
4 |
VYNE Therapeutics
VYNE
|
$12.8M |
5 |
Ascendis Pharma
ASND
|
$5.45M |
Sector Composition
1 | Healthcare | 96.17% |